Skip to main content
Top
Published in: Annals of Nuclear Medicine 4/2009

01-06-2009 | Original Article

Measurement of cerebral blood flow by the autoradiographic method with N-isopropyl-4-[I-123] iodoamphetamine: comparison of radiopharmaceuticals marketed by different companies in Japan

Authors: Toshiyuki Ogura, Hiroshi Ito, Kazuhiro Hida, Toshihide Masuzuka, Hiroshi Fukuda, Jun Hatazawa

Published in: Annals of Nuclear Medicine | Issue 4/2009

Login to get access

Abstract

Objective

Iodine-123-labeled N-isopropyl-4-iodoamphetamine (IMP) is used as a tracer for the measurement of cerebral blood flow (CBF) by single-photon emission computed tomography (SPECT). Two IMP products, IMPA (Nihon Medi-Physics Co., Ltd.) and IMPB (FUJIFILM RI Pharma Co., Ltd.), produced by different radiopharmaceutical companies are marketed for clinical use in Japan. Although no significant difference in whole-body distribution between the two products has been reported, a significant difference in the radioactivity of the octanol-extracted fraction in whole blood between the two products has been reported in humans. In this study, CBF values obtained by the autoradiographic (ARG) method obtained from both IMPA and IMPB were compared in the same human subjects.

Methods

SPECT studies were performed on 6 healthy subjects with the use of both IMPA and IMPB. Standard input functions used in the ARG method were obtained for both IMPA and IMPB from 5 additional healthy subjects.

Results

Significant differences were found between CBF values when SPECT data with IMPA was combined with the standard input function for IMPB (37.7 ± 3.7 mL/100 g/min at a mid-scan time of 30 min) and SPECT data with IMPB was combined with the standard input function for IMPA (50.7 ± 8.9 mL/100 g/min). Nearly the same CBF values were found when SPECT data with IMPA was combined with the standard input function for IMPA (43.1 ± 4.4 mL/100 g/min) and SPECT data with IMPB was combined with the standard input function for IMPB (44.2 ± 7.6 mL/100 g/min).

Conclusions

Our results suggest that the appropriate standard input function should be used, according to the IMP product used, in the calculation of CBF by the ARG method.
Literature
1.
go back to reference Winchell HS, Baldwin RM, Lin TH. Development of I-123-labeledamines for brain studies: localization of I-123 iodophenylalkyl amines in rat brain. J Nucl Med. 1980;21:940–6.PubMed Winchell HS, Baldwin RM, Lin TH. Development of I-123-labeledamines for brain studies: localization of I-123 iodophenylalkyl amines in rat brain. J Nucl Med. 1980;21:940–6.PubMed
2.
go back to reference Winchell HS, Horst WD, Braun L, Oldendorf WH, Hattner R, Parker H. N-isopropyl-[123I] p-iodoamphetamine: single-pass brain uptake and washout; binding to brain synaptosomes; and localization in dog and monkey brain. J Nucl Med. 1980;21:947–52.PubMed Winchell HS, Horst WD, Braun L, Oldendorf WH, Hattner R, Parker H. N-isopropyl-[123I] p-iodoamphetamine: single-pass brain uptake and washout; binding to brain synaptosomes; and localization in dog and monkey brain. J Nucl Med. 1980;21:947–52.PubMed
3.
go back to reference Ito H, Iida H, Bloomfield PM, Murakami M, Inugami A, Kanno I, et al. Rapid calculation of regional cerebral blood flow and distribution volume using iodine-123-iodoamphetamine and dynamic SPECT. J Nucl Med. 1995;36:531–6.PubMed Ito H, Iida H, Bloomfield PM, Murakami M, Inugami A, Kanno I, et al. Rapid calculation of regional cerebral blood flow and distribution volume using iodine-123-iodoamphetamine and dynamic SPECT. J Nucl Med. 1995;36:531–6.PubMed
4.
go back to reference Ito H, Sato T, Odagiri H, Inoue K, Shidahara M, Suhara T, et al. Brain and whole body distribution of N-isopropyl-4-iodoamphetamine (I-123) in humans: comparison of radiopharmaceuticals marketed by different companies in Japan. Ann Nucl Med. 2006;20:493–8.PubMedCrossRef Ito H, Sato T, Odagiri H, Inoue K, Shidahara M, Suhara T, et al. Brain and whole body distribution of N-isopropyl-4-iodoamphetamine (I-123) in humans: comparison of radiopharmaceuticals marketed by different companies in Japan. Ann Nucl Med. 2006;20:493–8.PubMedCrossRef
5.
go back to reference Kanai Y, Hasegawa S, Kimura Y, Oku N, Ito H, Fukuda H, et al. N-isopropyl-4-[123I] iodoamphetamine (123I-IMP) products: difference in radiochemical purity, unmetabolized fraction and octanol extraction fraction in arterial blood, and regional brain uptake in rats. Ann Nucl Med. 2007;21:387–91.PubMedCrossRef Kanai Y, Hasegawa S, Kimura Y, Oku N, Ito H, Fukuda H, et al. N-isopropyl-4-[123I] iodoamphetamine (123I-IMP) products: difference in radiochemical purity, unmetabolized fraction and octanol extraction fraction in arterial blood, and regional brain uptake in rats. Ann Nucl Med. 2007;21:387–91.PubMedCrossRef
6.
go back to reference Iida H, Itoh H, Nakazawa M, Hatazawa J, Nishimura H, Onishi Y, et al. Quantitative mapping of regional cerebral blood flow using iodine-123-IMP and SPECT. J Nucl Med. 1994;35:2019–30.PubMed Iida H, Itoh H, Nakazawa M, Hatazawa J, Nishimura H, Onishi Y, et al. Quantitative mapping of regional cerebral blood flow using iodine-123-IMP and SPECT. J Nucl Med. 1994;35:2019–30.PubMed
7.
go back to reference Ito H, Ishii K, Atsumi H, Inukai Y, Abe S, Sato M, et al. Error analysis of autoradiography method for measurement of cerebral blood flow by 123I-IMP brain SPECT: a comparison study with table look-up method and microsphere model method. Ann Nucl Med. 1995;9:185–90.PubMedCrossRef Ito H, Ishii K, Atsumi H, Inukai Y, Abe S, Sato M, et al. Error analysis of autoradiography method for measurement of cerebral blood flow by 123I-IMP brain SPECT: a comparison study with table look-up method and microsphere model method. Ann Nucl Med. 1995;9:185–90.PubMedCrossRef
8.
go back to reference Iida H, Akutsu T, Endo K, Fukuda H, Inoue T, Ito H, et al. A multicenter validation of regional cerebral blood flow quantitation using [123I]iodoamphetamine and single photon emission computed tomography. J Cereb Blood Flow Metab. 1996;16:781–93.PubMedCrossRef Iida H, Akutsu T, Endo K, Fukuda H, Inoue T, Ito H, et al. A multicenter validation of regional cerebral blood flow quantitation using [123I]iodoamphetamine and single photon emission computed tomography. J Cereb Blood Flow Metab. 1996;16:781–93.PubMedCrossRef
9.
go back to reference Shiga T, Kaji T, Kohno T, Kageyama H, Katoh C, Harazawa J, et al. Evaluation of the products specific standard input function for the IMP-ARG method. KakuIgaku. 2007;44:1–7. Shiga T, Kaji T, Kohno T, Kageyama H, Katoh C, Harazawa J, et al. Evaluation of the products specific standard input function for the IMP-ARG method. KakuIgaku. 2007;44:1–7.
10.
go back to reference Kuhl DE, Barrio JR, Huang SC, Selin C, Ackermann RF, Lear JL, et al. Quantifying local cerebral blood flow by N-isopropyl-p-[123I]iodoamphetamine (IMP) tomography. J Nucl Med. 1982;23:196–203.PubMed Kuhl DE, Barrio JR, Huang SC, Selin C, Ackermann RF, Lear JL, et al. Quantifying local cerebral blood flow by N-isopropyl-p-[123I]iodoamphetamine (IMP) tomography. J Nucl Med. 1982;23:196–203.PubMed
11.
go back to reference Kimura K, Hashikawa K, Etani H, Uehara A, Kozuka T, Moriwaki H, et al. A new apparatus for brain imaging: four-head rotating gamma camera single-photon emission computed tomograph. J Nucl Med. 1990;31:603–9.PubMed Kimura K, Hashikawa K, Etani H, Uehara A, Kozuka T, Moriwaki H, et al. A new apparatus for brain imaging: four-head rotating gamma camera single-photon emission computed tomograph. J Nucl Med. 1990;31:603–9.PubMed
12.
go back to reference Chang LT. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci. 1978;25:638–43.CrossRef Chang LT. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci. 1978;25:638–43.CrossRef
13.
go back to reference Chang LT. Attenuation correction and incomplete projection in single photon emission computed tomography. IEEE Trans Nucl Sci. 1979;26:2780–9.CrossRef Chang LT. Attenuation correction and incomplete projection in single photon emission computed tomography. IEEE Trans Nucl Sci. 1979;26:2780–9.CrossRef
14.
go back to reference Friston KJ, Frith CD, Liddle PF, Dolan RJ, Lammertsma AA, Frackowiak RS. The relationship between global and local changes in PET scans. J Cereb Blood Flow Metab. 1990;10:458–66.PubMed Friston KJ, Frith CD, Liddle PF, Dolan RJ, Lammertsma AA, Frackowiak RS. The relationship between global and local changes in PET scans. J Cereb Blood Flow Metab. 1990;10:458–66.PubMed
15.
go back to reference Iida H, Itoh H, Bloomfield PM, Munaka M, Higano S, Murakami M, et al. A method to quantitate cerebral blood flow using a rotating gamma camera and iodine-123 iodoamphetamine with one blood sampling. Eur J Nucl Med. 1994;21:1072–84.PubMedCrossRef Iida H, Itoh H, Bloomfield PM, Munaka M, Higano S, Murakami M, et al. A method to quantitate cerebral blood flow using a rotating gamma camera and iodine-123 iodoamphetamine with one blood sampling. Eur J Nucl Med. 1994;21:1072–84.PubMedCrossRef
16.
go back to reference Ohta H, Utsunomiya K, Hayashi M, Komori T, Ogura Y, Adachi I, et al. Measurement of cerebral blood flow with N-isopropyl-4-iodoamphetamine (123I) hydrochloride autoradiography: comparison of two different products. Radioisotopes. 2004;53:477–82. Ohta H, Utsunomiya K, Hayashi M, Komori T, Ogura Y, Adachi I, et al. Measurement of cerebral blood flow with N-isopropyl-4-iodoamphetamine (123I) hydrochloride autoradiography: comparison of two different products. Radioisotopes. 2004;53:477–82.
Metadata
Title
Measurement of cerebral blood flow by the autoradiographic method with N-isopropyl-4-[I-123] iodoamphetamine: comparison of radiopharmaceuticals marketed by different companies in Japan
Authors
Toshiyuki Ogura
Hiroshi Ito
Kazuhiro Hida
Toshihide Masuzuka
Hiroshi Fukuda
Jun Hatazawa
Publication date
01-06-2009
Publisher
Springer Japan
Published in
Annals of Nuclear Medicine / Issue 4/2009
Print ISSN: 0914-7187
Electronic ISSN: 1864-6433
DOI
https://doi.org/10.1007/s12149-009-0242-8

Other articles of this Issue 4/2009

Annals of Nuclear Medicine 4/2009 Go to the issue